Neoplasms Metastasis Terminated Phase 2 Trials for Doxorubicin (DB00997)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00377780Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast CancerTreatment